| | Liver status prior to COVID-19 | |
| | Cirrhosis, (%) | 64 (24.2) | | Cirrhosis characteristics and ethology | | | Alcohol, (%) | 40 (62.5) | | Nonalcoholic steatohepatitis, (%) | 8 (12.5) | | Unknown, (%) | 5 (7.8) | | Hepatitis C, (%) | 3 (4.7) | | Hepatitis B, (%) | 2 (3.1) | | Alcohol+hepatitis C, (%) | 2 (3.1) | | Alcohol+nonalcoholic steatohepatitis, (%) | 1 (1.6) | | Alcohol+autoimmune hepatitis, (%) | 1 (1.6) | | NASH+hepatitis B, (%) | 1 (1.6) | | Alpha-1-antitrypsin deficiency, (%) | 1 (1.6) | | Acute on chronic liver failure, (%) | 11 (17.2) | | MELD score (), mean (SD) | 13.34 (6.4) | | MELD , (%) | 19 (33.9) | | Charlson Comorbidity Index, mean (SD) | 5.41 (1.8) | | Child-Pugh score () | | | Child-Pugh A (5, 6), (%) | 18 (41.9) | | Child-Pugh B (7–9), (%) | 18 (41.9) | | Child-Pugh C (10–15), (%) | 7 (16.3) | | Procedures | | | Large volume paracentesis, (%) | 4 (6.3) | | Banding of varices, (%) | 6 (9.4) | | TIPS placement, (%) | 2 (3.1) | | Liver transplantation, (%) | 0 (0) |
|
|
